All conditions

Type 2 Diabetes

Plain English clinical trial information, updated daily from ClinicalTrials.gov and public government registries. Not medical advice.

64
Trials tracked
1
Recruiting now
32
Australian sites
60
Countries
Country

Showing 64 trials

🇦🇺 AU site

Trial: NCT06473831 — GT Metabolic Solutions, Inc.

NCT06473831 · GT Metabolic Solutions, Inc.
Active, Not Recruiting Not Applicable Est. completion 4 September 2025
🇦🇺 AU

**Who might be able to join this trial:** - You are between 18 and 65 years old at the time of signing the consent form - Your Body Mass Index (BMI) is between 30 and 50 (a measure of weight relative to height) - You have Type 2 diabetes (w...

🇦🇺 AU site

Trial: NCT02240680 — Boehringer Ingelheim

NCT02240680 · Boehringer Ingelheim
Completed Phase 4 Est. completion 18 April 2017
🇦🇺 AU 🇧🇪 BE 🇨🇴 CO 🇩🇰 DK 🇫🇮 FI

**Who might be able to join this trial:** - You must be willing to sign a consent form agreeing to take part in the trial before any assessments begin. - You must have been diagnosed with Type 2 Diabetes. - You must be 60 years of age or o...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT02009813 — University of Adelaide

NCT02009813 · University of Adelaide
Completed Not Applicable Est. completion 1 March 2014
🇦🇺 AU

**Who might be able to join this trial:** - You have a Body Mass Index (BMI) between 25 and 35, which means you are considered overweight to obese (your doctor or the trial site can check your BMI for you) - You are older than 18 years of a...

🇦🇺 AU site

Trial: NCT02320721 — Sanofi

NCT02320721 · Sanofi
Completed Phase 3 Est. completion 1 May 2016
🇦🇷 AR 🇦🇺 AU 🇨🇦 CA 🇨🇴 CO 🇫🇷 FR

**Who might be able to join this trial:** - You are 65 years old or older and have been diagnosed with type 2 diabetes that is not well controlled by your current diabetes medications - Your current diabetes treatment includes either no ins...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT01106625 — Janssen Research & Development, LLC

NCT01106625 · Janssen Research & Development, LLC
Completed Phase 3 Est. completion 1 September 2011
🇦🇺 AU 🇧🇪 BE 🇫🇷 FR Guatemala 🇭🇺 HU

Who might be able to join this trial: - You must have been diagnosed with type 2 diabetes and currently be taking two specific diabetes medications: metformin and a sulphonylurea (a type of diabetes pill). - Your HbA1c (a blood test showing...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00069784 — Sanofi

NCT00069784 · Sanofi
Completed Phase 3 Est. completion 1 December 2011
🇦🇷 AR 🇦🇺 AU 🇦🇹 AT Belarus Bermuda

Who might be able to join this trial: - You have been found to have higher-than-normal blood sugar levels (either mildly high fasting sugar, mildly high sugar after eating, or early type 2 diabetes) based on a specific blood sugar test. - I...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT01224366 — Novartis

NCT01224366 · Novartis
Completed Phase 3 Est. completion 1 October 2011
🇦🇺 AU 🇧🇪 BE 🇨🇿 CZ 🇩🇪 DE Guatemala

**Who might be able to join this trial:** - You have been diagnosed with Type 2 diabetes - You are taking insulin at a stable, consistent dose as set out by the trial rules - If you take metformin, you have been taking it at a stable, consi...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00379769 — GlaxoSmithKline

NCT00379769 · GlaxoSmithKline
Completed Phase 3 Est. completion 1 December 2008
🇦🇺 AU 🇧🇪 BE 🇧🇬 BG 🇭🇷 HR 🇨🇿 CZ

Who might be able to join this trial: - You have been diagnosed with Type 2 diabetes, as defined by World Health Organisation guidelines. - Your blood sugar control level (measured by an HbA1c blood test) is between 7.0% and 9.0% at your fi...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT01649297 — Boehringer Ingelheim

NCT01649297 · Boehringer Ingelheim
Completed Phase 2 Est. completion 1 December 2013
🇦🇺 AU 🇨🇦 CA 🇪🇪 EE 🇫🇷 FR 🇬🇪 GE

Who might be able to join this trial: - You have been diagnosed with Type 2 diabetes - Your HbA1c blood sugar level (a measure of average blood sugar over 2–3 months) is between 7.0% and 10.0% - You are already taking Metformin at a dose of...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00703482 — Solvay Pharmaceuticals

NCT00703482 · Solvay Pharmaceuticals
Completed Phase 2 Est. completion 1 September 2004
🇦🇺 AU

**Who might be able to join this trial:** - You are a man or woman between 40 and 79 years old - You have already been diagnosed with Type 2 diabetes - Your HbA1c (a blood test that shows average blood sugar levels over the past few months)...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00239538 — Boehringer Ingelheim

NCT00239538 · Boehringer Ingelheim
Completed Phase 4 Est. completion 1 December 2004
🇦🇷 AR 🇦🇺 AU 🇨🇦 CA 🇲🇽 MX 🇳🇿 NZ

Who might be able to join this trial: - You must be able to read and sign a consent form agreeing to take part. - You must have high blood pressure, with specific readings recorded at a clinic visit (diastolic pressure between 95–109 and/or...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT01726621 — Medtronic MiniMed, Inc.

NCT01726621 · Medtronic MiniMed, Inc.
Completed Not Applicable Est. completion 1 November 2014
🇦🇺 AU 🇩🇰 DK 🇪🇸 ES 🇬🇧 GB

Who might be able to join this trial: - You must be 7 years old or older at the time of screening - You must have been using an insulin pump for at least 3 months - You must be experienced with continuous glucose monitoring, meaning you can...

🇦🇺 AU site

Trial: NCT01200394 — Pfizer

NCT01200394 · Pfizer
Completed Phase 2 Est. completion 1 July 2013
🇦🇺 AU 🇨🇦 CA 🇩🇰 DK Hong Kong 🇮🇳 IN

Who might be able to join this trial: - You are 18 years old or older, and if you are female, you must not be able to become pregnant. - You have been diagnosed with type 2 diabetes and have moderate-to-severe chronic kidney disease, based...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT04707469 — Novo Nordisk A/S

NCT04707469 · Novo Nordisk A/S
Completed Phase 3 Est. completion 7 March 2023
🇦🇺 AU 🇧🇬 BG 🇨🇦 CA 🇭🇷 HR 🇨🇿 CZ

**Who might be able to join this trial:** - You are 18 years old or older at the time of signing the consent form. - You have been diagnosed with type 2 diabetes for at least 6 months before the screening visit. - Your HbA1c (a blood test t...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00422253 — Bayside Health

NCT00422253 · Bayside Health
Completed Not Applicable Est. completion 1 December 2012
🇦🇺 AU

**Who might be able to join this trial:** - You are between 18 and 50 years old - You are overweight or obese, meaning your Body Mass Index (BMI) is 25 or higher - Your weight has been stable recently (not changing much) - You do not have d...

🇦🇺 AU site

Trial: NCT00949286 — The George Institute

NCT00949286 · The George Institute
Completed Not Applicable Est. completion 1 February 2014
🇦🇺 AU 🇨🇦 CA 🇨🇳 CN 🇨🇿 CZ 🇪🇪 EE

Who might be able to join this trial: - You previously took part in a study called ADVANCE - You are able to understand and sign a consent form agreeing to take part in the study Who may not be able to join: - There are no stated reasons t...

🇦🇺 AU site

Trial: NCT00613782 — Austin Health

NCT00613782 · Austin Health
Completed Phase 3 Est. completion 1 January 2014
🇦🇺 AU

Who might be able to join this trial: - You have been diagnosed with Type 2 diabetes - Your testosterone level is below a certain low level (less than 10 nmol/L — confirm with trial site for what this means for you) Who may not be able to...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT01043029 — Hoffmann-La Roche

NCT01043029 · Hoffmann-La Roche
Completed Phase 2 Est. completion 1 July 2012
🇦🇺 AU 🇧🇷 BR 🇨🇴 CO El Salvador 🇩🇪 DE

Who might be able to join this trial: - You must be 18 years of age or older - You must have been diagnosed with Type 2 diabetes - You must have moderately reduced kidney function - You must either be taking no diabetes medications, or be o...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT03214380 — Eli Lilly and Company

NCT03214380 · Eli Lilly and Company
Completed Phase 3 Est. completion 14 August 2018
🇦🇷 AR 🇦🇺 AU 🇨🇿 CZ 🇩🇪 DE 🇭🇺 HU

**Who might be able to join this trial:** - You have been diagnosed with type 2 diabetes (based on World Health Organization guidelines) for at least 1 year before the screening visit. - You have been using a long-acting (basal) insulin plu...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00240383 — Bristol-Myers Squibb

NCT00240383 · Bristol-Myers Squibb
Completed Phase 3 Est. completion 1 June 2006
🇦🇷 AR 🇦🇺 AU 🇧🇷 BR 🇨🇦 CA 🇨🇿 CZ

Who might be able to join this trial: - You are between 18 and 70 years old (male or female) - You have been diagnosed with Type 2 diabetes - Your HbA1c blood sugar level (a measure of average blood sugar over time) was between 7.0% and 10....

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00460941 — Hoffmann-La Roche

NCT00460941 · Hoffmann-La Roche
Completed Phase 2 Est. completion 1 January 2008
🇦🇺 AU 🇫🇷 FR 🇩🇪 DE 🇲🇽 MX 🇵🇪 PE

**Who might be able to join this trial:** - Men, or women who have gone through menopause or have been surgically sterilized, between 18 and 75 years old - People who have type 2 diabetes and have been taking metformin at a stable dose for...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT01989754 — Janssen Research & Development, LLC

NCT01989754 · Janssen Research & Development, LLC
Completed Phase 4 Est. completion 23 February 2017
🇦🇷 AR 🇦🇺 AU 🇧🇪 BE 🇧🇷 BR 🇨🇦 CA

**Who might be able to join this trial:** - You have been diagnosed with type 2 diabetes. - Your blood sugar is not well controlled, meaning a recent blood test (called an HbA1c) showed a result between 7.0% and 10.5%. - You are 30 years of...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT05814107 — Carmot Australia First Pty Ltd

NCT05814107 · Carmot Australia First Pty Ltd
Completed Phase 1 Est. completion 7 November 2025
🇦🇺 AU 🇲🇽 MX

Who might be able to join this trial: - You are between 18 and 65 years old - Your BMI (a measure of body weight relative to height) is between 25 and 40 - Your weight has been stable for the past two months - For one specific part of the t...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00168519 — Baker Heart Research Institute

NCT00168519 · Baker Heart Research Institute
Completed Not Applicable
🇦🇺 AU

Who might be able to join this trial: **For people with type 2 diabetes:** - You do not smoke - You do not have obvious heart disease, confirmed by a stress heart test (ECG) - Your body weight falls within a certain range (your Body Mass I...

🇦🇺 AU site

Trial: NCT01068860 — Novartis

NCT01068860 · Novartis
Completed Phase 2 Est. completion 1 August 2010
🇦🇺 AU 🇨🇦 CA 🇫🇮 FI 🇩🇪 DE 🇮🇳 IN

**Who might be able to join this trial:** - You have been told you have "impaired glucose tolerance" (a condition where blood sugar is higher than normal but not yet diabetes) and are not taking any diabetes medication, OR you have Type 2...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00546325 — Sanofi

NCT00546325 · Sanofi
Completed Phase 3 Est. completion 1 February 2009
🇦🇺 AU

Who might be able to join this trial: - You have been diagnosed with Type 2 diabetes - Your HbA1c (a blood sugar level test) result is between 7% and 9% - Your Body Mass Index (BMI) is between 27 and 40 - You are currently taking both Metfo...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT01798706 — Sanofi

NCT01798706 · Sanofi
Completed Phase 3 Est. completion 1 February 2015
🇦🇺 AU 🇧🇬 BG 🇨🇦 CA 🇩🇰 DK 🇩🇪 DE

**Who might be able to join this trial:** - You are aged 70 years or older and have been diagnosed with type 2 diabetes that is not well controlled with your current diabetes medications - You are willing and able to sign a consent form agr...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00754988 — Hoffmann-La Roche

NCT00754988 · Hoffmann-La Roche
Completed Phase 3 Est. completion 1 March 2011
🇦🇷 AR 🇦🇺 AU 🇨🇦 CA 🇫🇷 FR 🇩🇪 DE

**Who might be able to join this trial:** - You are between 18 and 75 years old - You have type 2 diabetes and have been taking metformin (at least 1500mg per day) for at least 12 weeks - Your HbA1c blood sugar level (a measure of average b...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT05633810 — Montreal Heart Institute

NCT05633810 · Montreal Heart Institute
Recruiting Phase 3 Est. completion 1 December 2027
🇦🇺 AU 🇨🇦 CA 🇩🇰 DK 🇫🇮 FI 🇫🇷 FR

**Who might be able to join this trial:** - You are a man or woman between 55 and 80 years old - You have been diagnosed with type 2 diabetes and are being treated for it according to standard medical guidelines - You have never had a hear...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT00391196 — Pfizer

NCT00391196 · Pfizer
Terminated Phase 3 Est. completion 1 December 2008
🇦🇷 AR 🇦🇺 AU 🇧🇷 BR 🇨🇦 CA 🇨🇿 CZ

Who might be able to join this trial: - You are overweight, with a Body Mass Index (BMI) between 27 and 50 (a number calculated from your height and weight) - You have been diagnosed with type 2 diabetes Who may not be able to join: - You...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT03993379 — CytomX Therapeutics

NCT03993379 · CytomX Therapeutics
Terminated Phase 2 Est. completion 21 May 2020
🇦🇺 AU 🇳🇱 NL 🇰🇷 KR 🇪🇸 ES 🇺🇸 US

**Who might be able to join this trial:** - You are 18 years of age or older - Your cancer can be measured on scans, as defined by a standard medical measurement system called RECIST v1.1 (confirm with trial site) - You are generally able t...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)
🇦🇺 AU site

Trial: NCT02236962 — Bayside Health

NCT02236962 · Bayside Health
UNKNOWN Not Applicable Est. completion 1 December 2014
🇦🇺 AU

Who might be able to join this trial: - You are male and between 19 and 35 years old - You have no known heart disease, based on your medical history, a physical examination, and a heart tracing (ECG) - You are not currently taking any medi...

Trial: NCT05945862 — Instituto Tecnologico de Sonora

NCT05945862 · Instituto Tecnologico de Sonora
Completed Not Applicable Est. completion 31 December 2025
🇲🇽 MX

**Who might be able to join this trial:** - Children between the ages of 7 and 12 years old - Parents, including fathers, mothers, or legal guardians, as long as they are adults - Families who currently live in Yaqui Valley, Sonora, Mexico...

Trial: NCT01053936 — Biogen

NCT01053936 · Biogen
Completed Phase 2 Est. completion 31 December 2010
🇺🇸 US

**Who might be able to join this trial:** - You have been diagnosed with type 2 diabetes, and that diagnosis was made when you were older than 30 years of age (if you were younger at diagnosis, a special blood test may be used to confirm t...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT00877851 — Queen's University, Belfast

NCT00877851 · Queen's University, Belfast
Completed Not Applicable Est. completion 1 December 2010
🇬🇧 GB

Who might be able to join this trial: - You have been medically diagnosed with Type 2 diabetes within the last 2 years - You have regular access to a computer Who may not be able to join: - You are currently pregnant or breastfeeding - You...

Trial: NCT01154881 — Novo Nordisk A/S

NCT01154881 · Novo Nordisk A/S
Completed Phase 1 Est. completion 1 November 2010
🇩🇪 DE

Who might be able to join this trial: - You have been diagnosed with type 2 diabetes for at least 12 months - Your body mass index (BMI) is 35.0 or below (BMI is a measure based on your height and weight) Who may not be able to join: - You...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT07030543 — Khyber Medical University Peshawar

NCT07030543 · Khyber Medical University Peshawar
Completed Not Applicable Est. completion 10 July 2025
🇵🇰 PK

Who might be able to join this trial: - You are 18 years old or older and have been diagnosed with Type 2 Diabetes by a doctor. - You are currently receiving care at the Diabetes Hospital and Research Centre in Peshawar. - You are willing t...

Trial: NCT00707616 — Mayo Clinic

NCT00707616 · Mayo Clinic
Completed Not Applicable Est. completion 1 December 2012
🇺🇸 US

Who might be able to join this trial: - Your fasting blood sugar level (measured after not eating) is below 126 mg/dL Who may not be able to join: - Your fasting blood sugar level (measured after not eating) is above 126 mg/dL Important:...

Trial: NCT04091373 — MedImmune LLC

NCT04091373 · MedImmune LLC
Completed Phase 1 Est. completion 6 March 2020
🇺🇸 US

**Who might be able to join this trial:** - You are a healthy adult between 18 and 60 years old (inclusive) at the time of screening. - You are willing and able to give your consent to take part, either in writing or electronically, before...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT00522158 — Baskent University

NCT00522158 · Baskent University
Completed Phase 4

Who might be able to join this trial: - People who have type 2 diabetes that is well managed (controlled) AND who have already been diagnosed with heart or blood vessel disease. - People who have type 2 diabetes that is well managed (contro...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT02211261 — Pfizer

NCT02211261 · Pfizer
Completed Phase 1 Est. completion 27 January 2017
🇺🇸 US

**Who might be able to join this trial:** - Men and women with Type 2 Diabetes who are not able to become pregnant - People who have been taking a stable dose of the diabetes medication metformin (at least 1500mg per day for one part of the...

Phase 1: ~10% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT05260983 — University of Oregon

NCT05260983 · University of Oregon
Completed Not Applicable Est. completion 4 September 2021
🇺🇸 US

Here is the eligibility information in plain English: **Who might be able to join this trial:** - You must currently live in the United States - You must have a 90% or higher task completion rating on the Amazon Mechanical Turk (mTurk) pla...

Trial: NCT01007266 — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT01007266 · National Institute of Diabetes and Digestive and K...
Completed Phase 2
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with type 2 diabetes by your doctor. - You are between 12 and 20 years old when you join the trial. - Your most recent HbA1c blood sugar level result was 7% or higher (this is...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT02026024 — Chang Gung Memorial Hospital

NCT02026024 · Chang Gung Memorial Hospital
Completed Not Applicable Est. completion 1 December 2015
🇹🇼 TW

"Who might be able to join this trial: - You are older than 20 years of age - You have been diagnosed with diabetes for more than 2 years - Your HbA1c (a blood test that measures average blood sugar levels over the past few months) is betwe...

Trial: NCT01194479 — Yale University

NCT01194479 · Yale University
Completed Not Applicable Est. completion 1 August 2014
🇺🇸 US

Who might be able to join this trial: - You have been diagnosed with type 1 diabetes that is considered well controlled, but you still experience about 2 to 3 low blood sugar episodes per week. - You are between 18 and 50 years old. - Your...

Trial: NCT02423850 — Odense University Hospital

NCT02423850 · Odense University Hospital
Completed Not Applicable Est. completion 1 December 2018
🇩🇰 DK

Who might be able to join this trial: - You have recently been admitted to hospital with a diabetic foot ulcer - You are 18 years of age or older Who may not be able to join: - Your wound is very small and shallow (smaller than 5x5 mm and...

Trial: NCT01904383 — Boehringer Ingelheim

NCT01904383 · Boehringer Ingelheim
Completed Not Applicable Est. completion 4 October 2018
🇯🇵 JP

Who might be able to join this trial: - You have been diagnosed with type 2 diabetes and are currently taking medication to manage your blood sugar - You have never previously taken the medication called Trazenta® (linagliptin) before joini...

Trial: NCT07070830 — Insulet Corporation

NCT07070830 · Insulet Corporation
Completed Not Applicable Est. completion 6 January 2026
🇺🇸 US

Who might be able to join this trial: - You are between 18 and 75 years old at the time of signing up. - You have been diagnosed with type 2 diabetes and have been using an insulin regimen (such as basal-bolus, basal only, or pre-mix insuli...

Trial: NCT07252609 — Federico II University

NCT07252609 · Federico II University
Completed Not Applicable Est. completion 8 August 2025
🇮🇹 IT

**Who might be able to join this trial:** - You are a man or woman who is overweight or obese, with a Body Mass Index (BMI) between 25.0 and 39.9 (this is a number calculated from your height and weight) - You may or may not have type 2 dia...

Trial: NCT01455441 — Tina Vilsboll

NCT01455441 · Tina Vilsboll
Completed Phase 4 Est. completion 1 June 2013
🇩🇰 DK

Who might be able to join this trial: - You are willing and able to give both spoken and written consent to take part - You have been diagnosed with type 2 diabetes according to World Health Organization guidelines - Your HbA1c (a blood sug...

Phase 4: Approved of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT03976271 — Radboud University Medical Center

NCT03976271 · Radboud University Medical Center
Completed Not Applicable Est. completion 31 March 2021
🇩🇰 DK 🇳🇱 NL

**Who might be able to join this trial:** - You are able to give written consent to take part in the study - You can speak and read Danish (if joining at the Hillerød site) or Dutch (if joining at the Nijmegen site) - You are managing your...

Trial: NCT03074383 — Hospital de Clinicas de Porto Alegre

NCT03074383 · Hospital de Clinicas de Porto Alegre
Completed Not Applicable Est. completion 31 December 2018
🇧🇷 BR

Who might be able to join this trial: - You have been diagnosed with type 2 diabetes - Your HbA1c blood sugar level is above 7.5% (this is a measure of your average blood sugar over the past few months — confirm with trial site if unsure of...

Trial: NCT04304430 — University of Padova

NCT04304430 · University of Padova
Completed Not Applicable Est. completion 26 December 2019
🇮🇹 IT

Who might be able to join this trial: - You have been diagnosed with type 2 diabetes - You are between 18 and 80 years old - You have had type 2 diabetes for more than 1 year - You are starting a medication called dapagliflozin or a DPP-4 i...

Trial: NCT00803920 — HealthPartners Institute

NCT00803920 · HealthPartners Institute
Completed Not Applicable Est. completion 1 February 2008
🇺🇸 US

**Who might be able to join this trial:** - You must already be a participant in a specific related Amylin study (Protocol 2993LAR-105) - You are at least 16 years old - You have type 2 diabetes that is being managed with a stable dose of c...

Trial: NCT06066021 — Association for Innovation and Biomedical Research on Light and Image

NCT06066021 · Association for Innovation and Biomedical Research...
Completed Not Applicable Est. completion 15 November 2023
🇵🇹 PT

**Who might be able to join this trial:** - You have been diagnosed with type 2 diabetes and are already taking part in either the STAR or EYEMARKER research studies - Your personal risk score for eye disease (measured using an app called R...

Trial: NCT03088670 — SatRx LLC

NCT03088670 · SatRx LLC
Completed Phase 3 Est. completion 30 March 2014
🇷🇺 RU

**Who might be able to join this trial:** - You are between 18 and 78 years old - You have been officially diagnosed with type 2 diabetes - You have either never taken diabetes medication, or you have not taken any diabetes-lowering medicat...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT00108901 — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00108901 · National Institute of Diabetes and Digestive and K...
Completed Phase 2 Est. completion 1 December 2006
🇺🇸 US

Who might be able to join this trial: - Children who are overweight and not very physically active - Children who are Black or white - Children who attend one of the specific schools in the Augusta, Georgia area that are part of this study...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT00153179 — Brigham and Women's Hospital

NCT00153179 · Brigham and Women's Hospital
Completed Phase 2 Est. completion 1 December 2011
🇺🇸 US

Who might be able to join this trial: - People who have been diagnosed with type 2 diabetes (as defined by the National Diabetes Data Group) - People who have a normal heart and blood vessel check-up result - People who have not smoked for...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT02235194 — Stoffwechselzentrum Rhein - Pfalz

NCT02235194 · Stoffwechselzentrum Rhein - Pfalz
Completed Not Applicable Est. completion 1 November 2015
🇩🇪 DE

Who might be able to join this trial: - You have been diagnosed with early Type 2 diabetes and are managing it with Metformin or diet alone (no other diabetes medications) - You have been told you have prediabetes, meaning your blood sugar...

Trial: NCT02252224 — AstraZeneca

NCT02252224 · AstraZeneca
Completed Not Applicable Est. completion 30 November 2016
🇰🇷 KR

Who might be able to join this trial: - You must be 18 years of age or older - You must have type 2 diabetes and be eligible to take the medication Forxiga based on the approved guidelines in your country - You must have signed and dated a...

Trial: NCT01477112 — Instituto Venezolano de Investigaciones Cientificas

NCT01477112 · Instituto Venezolano de Investigaciones Cientifica...
Completed Not Applicable Est. completion 1 December 2010
Venezuela

Who might be able to join this trial: - You have been diagnosed with Type 2 diabetes for at least 5 years. - You are currently being treated with diabetes pills (oral medication) to manage your blood sugar. - You attend regular monthly chec...

Trial: NCT04618744 — Oramed, Ltd.

NCT04618744 · Oramed, Ltd.
Completed Phase 2 Est. completion 27 June 2022
🇮🇱 IL 🇺🇸 US

**Who might be able to join this trial:** - You are between 18 and 70 years old (male or female). - Your Body Mass Index (BMI) is 25 or higher (considered overweight or obese). - You have been diagnosed with type 2 diabetes, confirmed by s...

Phase 2: ~30% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)

Trial: NCT02173834 — Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

NCT02173834 · Academisch Medisch Centrum - Universiteit van Amst...
Completed Not Applicable Est. completion 1 November 2013
🇳🇱 NL

Who might be able to join this trial: - You must be male - You must be of Caucasian (white European) background - You must be willing and able to give your consent to take part in the study - You must be between 18 and 40 years old - Your B...

Trial: NCT02577016 — Merck Sharp & Dohme LLC

NCT02577016 · Merck Sharp & Dohme LLC
Completed Phase 3 Est. completion 18 November 2016

Who might be able to join this trial: - You have been diagnosed with type 2 diabetes - Your blood sugar is not well controlled through diet, exercise, and a medication called ipragliflozin alone - Your HbA1c (a blood test that shows your av...

Phase 3: ~65% of drugs entering this phase reach regulatory approval (industry-wide historical average, not specific to this trial)